Bonferroni post-hoc comparisons showed that all dementia groups had higher levels of NfL when compared with controls: controls versus MCI+AD (F=−2.98, p=3.10e−2), versus LBD (F=−3.72, p=2.40e−3), versus FTD (F=−6.90, p=3.31e−10) and versus PSP (F=−4.48, p=1.08e−4). The gene discussed is NEFL; the disease is frontotemporal dementia.